IFI-M · CUB Tri-Axis Balanced Series

Specimen SS-F-M3-01925 // MULTI-AXIS · IFI-M

CUB Tri-Axis Balanced Series V-NP

Mentha × piperita

Peppermint

Tier VCUB Tri-Axis Balanced Series

Target Trait

2.5×

fold-change

Cooling+Umami+Bitter-Attenuation balanced tri-axis fold-change

Technical Specifications

SKU

SS-F-M3-01925

Genomic Edits

12

GC Content

48.5%

Construct Length

6,520 bp

Promoter System

Lipid nanoparticle / Ubiquitin

Expression System

Nanoparticle delivery

Host Strain

LNP-mediated

Receptor Target

TRPM8 + mGluR1 + TAS2R38 (suppression)

IFI Score

250

Pathway Edits

  • TRPM8 pathway primary gene cluster for cooling (IFI-C) tri-axis component
  • mGluR1 pathway primary gene cluster for umami (IFI-U) tri-axis component
  • TAS2R38 (suppression) pathway primary gene cluster for bitter-attenuation (IFI-B) tri-axis component
  • Tri-axis metabolic flux partitioning hub for concurrent CUB pathway operation
  • Cross-pathway regulatory circuit for balanced CUB triple-axis expression
  • Cofactor regeneration system (NADPH, ATP, acetyl-CoA) supporting triple-axis concurrent production

Key Interventions

Triple-axis receptor co-activation: TRPM8, mGluR1, and TAS2R38 (suppression) pathways simultaneously engineeredBalanced tri-axis expression strategy (CUB) with cross-pathway flux managementLNP-mediated delivery of triple-axis mRNA panel for transient expression profiling

IFI Subscale Profile

IFI Profile

IFI-S
—
IFI-U
—
IFI-B
—
IFI-K
—
IFI-C
—
IFI-P
—
IFI-A
—
IFI-F
—

Use Case

Tier V CUB triple-axis construct for advanced multi-modal sensory architecture combining cooling, umami, and bitter-attenuation axes. Suitable for ultra-premium ingredient formulation requiring certification across three simultaneous IFI receptor pathways.

License

$10249 · Tier V License

Includes full construct sequence, CRISPR guide designs, pathway edit specifications, flux balance analysis, and IFI validation data.

Already purchased?

Back to Multi-Axis · IFI-MAll Modalities